Related Experiment Video
Updated: Aug 15, 2026

Propagation of Homalodisca coagulata virus-01 via Homalodisca vitripennis Cell Culture
Published on: September 25, 2014
Molecular and biological changes associated with HeLa cell attenuation of wild-type yellow fever virus
L M Dunster1, H Wang, K D Ryman
1WHO Collaborating Centre for Arbovirus and Haemorrhagic Fever Reference and Research, Kenya Medical Research Institute, Nairobi, Kenya.
Abstract:
Six passages of the mosquito-borne flavivirus yellow fever (YF) wild-type strain Asibi in HeLa cells attenuated the virus for monkeys and newborn mice and resulted in loss of mosquito competence. Attenuation after the passage in HeLa cells was not unique to YF virus strain Asibi as demonstrated by the HeLa passage attenuation of wild-type YF virus strain French viscerotropic virus and YF vaccine virus 17D-204 for newborn mice. In contrast, wild-type strain Dakar 1279 and the French neurotropic vaccine virus remained virulent for newborn mice after six passages in HeLa cells. Thus not all strains of YF virus can be attenuated by passage in HeLa cells. Attenuation of YF virus strains Asibi and French viscerotropic virus was accompanied by alterations in the antigenic and biological properties of the viruses, including changes to envelope protein epitopes. Attenuation for newborn mice was coincidental with the acquisition by the HeLa-passaged viruses of the vaccine-specific envelope protein epitope recognized by monoclonal antibody H5. This suggests that this conformational change may play a role in the attenuation process. Wild-type Dakar 1279, which remained virulent for newborn mice after passage in HeLa cells, retained its wild-type antigenic character. The genome of Asibi HeLa p6 virus differed from wild-type Asibi virus by 29 nucleotides that encoded 10 amino acid substitutions: 5 in the envelope protein, 1 in NS2A, 3 in NS4B, and 1 in NS5. The substitution at NS4B-95 is seen in three different attenuation processes of wild-type YF virus, leading us to speculate that it is involved in the attenuation of virulence of wild-type strain Asibi.
Insights
Passaging yellow fever virus (YF) in HeLa cells can attenuate its virulence in animal models and reduce mosquito transmission. However, not all YF virus strains are attenuated by this method, suggesting strain-specific responses.
Area of Science:
- Virology
- Molecular Biology
- Immunology
Background:
- Yellow fever virus (YF) is a mosquito-borne flavivirus causing significant global health concerns.
- Attenuating YF virus is crucial for vaccine development and controlling outbreaks.
- Previous studies have explored various methods for YF virus attenuation.
Purpose of the Study:
- To investigate the effect of HeLa cell passage on the attenuation of different yellow fever virus strains.
- To identify viral changes associated with attenuation and loss of mosquito competence.
- To explore the role of specific viral mutations and epitope changes in the attenuation process.
Main Methods:
- Passaging wild-type and vaccine strains of yellow fever virus (YF) in HeLa cells.
- Assessing viral attenuation in monkeys and newborn mice.
- Evaluating mosquito competence after HeLa cell passage.
- Analyzing antigenic and biological properties, including envelope protein epitopes.
- Sequencing the viral genome to identify nucleotide and amino acid substitutions.
Main Results:
- Six passages in HeLa cells attenuated YF virus strains Asibi and French viscerotropic virus for monkeys and mice, and reduced mosquito competence.
- HeLa cell passage did not attenuate YF virus strains Dakar 1279 and French neurotropic vaccine virus.
- Attenuation was associated with changes in viral antigenic properties and acquisition of a vaccine-specific envelope protein epitope (H5).
- The Asibi HeLa p6 virus genome showed 29 nucleotide differences encoding 10 amino acid substitutions, including one at NS4B-95, implicated in attenuation.
Conclusions:
- HeLa cell passage can attenuate specific yellow fever virus strains, impacting virulence and mosquito transmission.
- The acquisition of the H5 epitope during HeLa passage may contribute to viral attenuation.
- Not all YF virus strains are amenable to attenuation by HeLa cell passage, highlighting strain-specific characteristics.
- The NS4B-95 substitution is a potential key factor in the attenuation of YF virus virulence.
Related Concept Videos
Viral Mutations
Yellow Fever

